Common questions about Xiapex (FAQ)
Q: Is Xiapex considered a biologic drug?
Yes, official product information classifies Xiapex (collagenase clostridium histolyticum) as a biologic drug and a biopharmaceutical. This means the active ingredient is a complex protein mixture derived from a living source, the bacterium Clostridium histolyticum.
Q: Why is Xiapex only available as an injection?
Xiapex is a protein-based enzyme administered as a local injection directly into the targeted fibrous tissue. According to regulatory information, this is required because the drug's mechanism of action must be highly localized to the treatment site. Regulatory information indicates the drug is designed for local action and would likely be ineffective if administered in an oral form.
Q: Can Xiapex also be used for Peyronie's disease in women?
No. Official labeling states that Xiapex is indicated only for the treatment of adult men with Peyronie's disease. Safety and effectiveness for treating this condition in women have not been established in the studies reviewed by regulatory authorities.
Q: How fast does Xiapex start working after the injection?
The drug's mechanism of action, which involves enzymatic activity to weaken tissue, begins locally after the injection. The treatment effect is then facilitated by a physical manipulation procedure that the healthcare professional performs approximately 24 to 72 hours later to physically disrupt the weakened cord or plaque.
Q: What are the main benefits of using Xiapex for Dupuytren's contracture?
Studies and official information indicate that Xiapex offers an approved non-surgical option for adult patients with a palpable cord. Clinical trials reviewed by regulatory authorities observed a reduction in the severity of the contracture and improvement in the range of motion in the treated finger joints.
Q: What are the long-term risks associated with Xiapex treatment?
Official labeling notes that the long-term safety of Xiapex is not fully characterized, as formal follow-up studies had limited observation windows. The potential impact of treatment on the future need for, or outcomes of, surgical intervention is not known.
Q: Can dietary supplements affect how Xiapex works?
Regulatory documents state that because Xiapex is administered locally and has no significant absorption into the bloodstream, no clinically relevant systemic interactions are expected with food, alcohol, or herbal products. This indicates that most common dietary supplements are not expected to interfere with the drug's action.
Q: Is it safe to drink alcohol during the Xiapex treatment period?
Official information confirms that no documented systemic pharmacokinetic interactions with alcohol exist. Due to its targeted, local administration and minimal systemic absorption, alcohol is not expected to interfere with the way the medicine works in the body.
Q: Is Xiapex treatment permanent, or can the condition return?
While studies tracked the condition's course for up to five years, official information indicates that the long-term effects, including the potential for the condition to return, are not fully established beyond the observation windows of the main studies.
Q: Do I need to do physical therapy after getting a Xiapex injection?
Follow-up care is required. For Peyronie's disease, patients are instructed on performing daily self-performed penile modeling exercises at home. For Dupuytren's contracture, patients are given instructions regarding splinting and prescribed exercises after the manipulation procedure.
Q: Is it normal for the injection site to feel numb for a while?
The drug label warns of the risk of nerve injury, which could potentially cause numbness or tingling. The drug label states that numbness or tingling can be a sign of nerve injury, which is a rare but serious risk. Any new or worsened symptoms of numbness should be promptly discussed with the healthcare professional.
Q: What should I avoid doing with my hand/penis after treatment?
Official prescribing information advises patients to avoid strenuous activity with the treated hand until instructed by the physician. Patients being treated for Peyronie’s disease must abstain from sexual activity for a specified period of time following the injection cycle.
Q: Why is Xiapex not used for contractures in other body parts?
Xiapex has only been studied in clinical trials and granted regulatory approval for the treatment of Dupuytren's contracture in the hand and Peyronie's disease in the penis. Its use is limited to these specific conditions as supported by the evidence submitted to government authorities.
Q: Does the severity of the condition affect Xiapex's effectiveness?
Official use is approved for patients who meet specific criteria, such as a Peyronie's curvature of at least 30 degrees or a Dupuytren's contracture with a palpable cord. While eligibility criteria are based on a minimum severity level, regulatory information does not detail how varying severity levels within the approved population affect the treatment outcome.
Q: Can Xiapex be used on multiple contractures at the same time?
No. Regulatory guidelines for Dupuytren's contracture state that only one cord must be treated at a time. If a patient has multiple affected areas, the treatment of each must be performed sequentially at separate visits.
Q: Does Xiapex affect fertility or pregnancy?
Official labeling states that there are no adequate and well-controlled studies on the use of Xiapex in pregnant women. Therefore, it is not known whether the drug can cause harm to an unborn baby or affect fertility.
Q: What are the ingredients listed on the Xiapex package insert?
The primary component is the active ingredient, Collagenase Clostridium histolyticum. Official regulatory documents list the full composition, including the inactive ingredients (excipients) necessary for the preparation, such as sodium.
Q: How should I prepare for a Xiapex injection appointment?
The regulatory guidelines advise patients to discuss with their healthcare professional any medications that affect blood clotting, such as anticoagulants (blood thinners). This is because caution is required if these types of medicines (other than low-dose aspirin) are administered within seven days prior to the injection.
Q: Can Xiapex interact with oral contraceptives?
Regulatory labeling confirms that no clinically relevant systemic interactions are expected between Xiapex and oral contraceptives. This is because the drug is locally administered and does not interact with the major enzyme systems (P450) that metabolize contraceptives.
Q: How is the Xiapex injection administered for Peyronie's disease?
For Peyronie's disease, the drug is injected directly into the plaque by a trained specialist as part of a restricted access program. Care must be taken to precisely place the drug while avoiding critical structures like the urethra, nerves, and blood vessels.
Q: Is there a maximum number of Xiapex treatments allowed?
Yes, there is a limit. For Dupuytren's contracture, a patient may receive up to a maximum of 3 injections per cord. For Peyronie's disease, the maximum is 4 treatment cycles (a total of 8 injections) per plaque.
Q: Is it possible to have no reaction to the Xiapex injection?
While some localized reactions like pain, bruising, and swelling are classified as Very Common (occurring in ge 1/10 individuals), the range of adverse reactions varies. Not every patient will experience every listed reaction, though some local reaction is common.
Q: What follow-up care is necessary after a Xiapex procedure?
Follow-up care is essential. It includes a mandatory finger extension or penile modeling procedure performed by a physician shortly after the injection. This is followed by specific patient instructions on at-home activities like splinting or self-modeling.
Q: What is the difference between a Xiapex reaction and an infection?
The drug label lists expected reactions such as pain, bruising, and swelling. Symptoms like fever, severe pain, or unexpected bleeding are not typical reactions and should be reported to the healthcare professional for evaluation.
